Discover 1,568 paid clinical trials in Newark, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,568
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Location: Jersey City NJ, Livingston NJ, Nashville TN,
Sponsor: AO Innovation Translation Center
Sex: All
Age: 18+
Code: NCT03378557
Recruiting
Tumor Grade Determines PD-1/PDL-1 Expression
for
Endometrial Cancer, Ovarian Cancer
Location: Jersey City NJ
Sponsor: RWJ Barnabas Health at Jersey City Medical Center
Sex: Female
Age: 0+
Code: NCT04528940
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Jersey City NJ, Livingston NJ, New York NY, Flushing NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07061964
Phase2, Recruiting
Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair Mutation
for
Cancer Gene Mutation, Lynch Syndrome, Endometrial Cancer,
Location: Jersey City NJ
Sponsor: RWJ Barnabas Health at Jersey City Medical Center
Sex: Female
Age: 0+
Code: NCT04516083
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Jersey City NJ, New York NY, New Brunswick NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04269902
Phase3, Recruiting
Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries
Sponsor: RWJ Barnabas Health at Jersey City Medical Center
Sex: Female
Age: 18+
Code: NCT03960970
Phase2, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Jersey City NJ, Livingston NJ, New York NY, Brooklyn NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05987241
Phase2, Phase3, Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer